Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TransDermal Systems is a specialty pharmaceutical company focused on the development and commercialization of advanced transdermal drug delivery technologies. The company utilizes its proprietary TDS platform to deliver a wide range of therapeutic agents through the skin, providing an effective alternative to oral and injectable administration routes. By enabling controlled and sustained release of medications, their systems aim to improve therapeutic outcomes, reduce systemic side effects, and enhance patient compliance. TDS collaborates with global pharmaceutical partners to reformulate existing compounds into innovative patch-based therapies across various therapeutic areas, including pain management and endocrinology. The company's technology is designed to handle both small molecules and more complex formulations that are traditionally difficult to deliver transdermally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TransDermal Systems.